Medvamc

Houston, Texas 77030

0 studies enrolling now · 5 studies all time

What they study most

Angioplasty, Transluminal, Percutaneous Coronary, Depression, Diabetes, Hepatitis C, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial — Completed
• Dose Finding Study in COPD — Completed
• Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy — Completed
• HOPE Pilot for Veterans With Complex Diabetes — Completed
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed